Mauricio Arruda is a Cardiology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 50 publications with 2,326 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Avenue
Cleveland, OH 44106
Telephone
216-844-3800Provider last certified this registry record 14 Jan 2021.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202519 payments
- Abbott LaboratoriesProgram year20257 payments
- Medtronic, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.3%Antiarrhythmic32.6%Amiodarone Hcl40%Dofetilide40%Flecainide Acetate19%Part D<11 patientsBeta blocker25.7%Metoprolol Succinate59%Metoprolol Tartrate41%Part D≥18 patientsBlood & clotting
41.7%Factor Xa inhibitor21.6%Eliquis81%Xarelto19%Part D<11 patientsP2Y12 inhibitor20.1%Clopidogrel100%Part D≥36 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes after ventricular tachycardia ablation in patients with left ventricular assist device: a retrospective multicenter cohort study
Journal of Interventional Cardiac Electrophysiology
2026 - Incidence, progression, and predictors of left atrial appendage sealing after Watchman FLX device implantation with computed tomographic assessment
Catheterization and Cardiovascular Interventions
2024 - Novel computed tomography angiography‐based sizing methodology for WATCHMAN FLX device in left atrial appendage closure
Journal of Cardiovascular Electrophysiology
2022 - Predictors of successful same‐day discharge and 1‐year outcomes after left atrial appendage closure
Catheterization and Cardiovascular Interventions
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”